Daniel G. Isom

Daniel G. Isom


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2021 in Biology
Verified
Journal Article
Open access
PDF file
SVSantiago Vilar
Santiago Vilar
DIDaniel G. Isom
Daniel G. Isom
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide crisis with profound effects on both public health and the economy. In order to combat the COVID-19 pandemic, research groups have shared viral genome sequence data through the Global Initiative on Sharing All Influenza Data (GISAID). Over the past year, ≈290,000 full SARS-CoV-2 proteome sequences have been deposited in the GISAID. Here, we used these sequences to assess the rate of nonsynonymous mutants over the entire viral proteome. Our analysis shows that SARS-CoV-2 proteins are mutating at substantially different rates, with most of the viral proteins exhibiting little mutational variability. As anticipated, our calculations capture previously reported mutations that arose in the first months of the pandemic, such as D614G (Spike), P323L (NSP12), and R203K/G204R (Nucleocapsid), but they also identify more recent mutations, such as A222V and L18F (Spike) and A220V (Nucleocapsid), among others. Our comprehensive temporal and geographical analyses show two distinct periods with different proteome mutation rates: December 2019 to July 2020 and August to December 2020. Notably, some mutation rates differ by geography, primarily during the latter half of 2020 in Europe. Furthermore, our structure-based molecular analysis provides an exhaustive assessment of SARS-CoV-2 mutation rates in the context of the current set of 3D structures available for SARS-CoV-2 proteins. This emerging sequence-to-structure insight is beginning to illuminate the site-specific mutational (in)tolerance of SARS-CoV-2 proteins as the virus continues to spread around the globe.

20 May 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NKN. J. Kapolka
N. J. Kapolka
GTG. J. Taghon
G. J. Taghon
JRJ. B. Rowe
J. B. Rowe
WMW. M. Morgan
W. M. Morgan
JEJ. F. Enten
J. F. Enten
DIDaniel G. Isom
Daniel G. Isom
Significance: G protein-coupled receptors (GPCRs) are the largest class of membrane receptors in humans. As such, GPCR signaling is central to human biology and medicine. While more than 30% of approved drugs target roughly 150 GPCRs, most receptors lack well-defined endogenous ligands and are currently not druggable. To address this challenge, we created DCyFIR, a GPCR screening platform for ligand and drug discovery. This technology enables the cost-effective profiling of ligands and drug compounds against mixtures of hundreds of GPCR-barcoded cell strains in a single experiment. Because ligands are tested against many receptors simultaneously, DCyFIR profiling will eventually enable the physical screening of huge numbers of compounds, bringing wet-laboratory experimental throughput a step closer to what is done in silico.

1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JRJacob B. Rowe
Jacob B. Rowe
NKNicholas J. Kapolka
Nicholas J. Kapolka
GTGeoffrey J. Taghon
Geoffrey J. Taghon
WMWilliam M. Morgan
William M. Morgan
DIDaniel G. Isom
Daniel G. Isom
Of the 800 G protein–coupled receptors (GPCRs) in humans, only three (GPR4, GPR65, and GPR68) regulate signaling in acidified microenvironments by sensing protons (H+). How these receptors have uniquely obtained this ability is unknown. Here, we show these receptors evolved the capability to sense H+ signals by acquiring buried acidic residues. Using our informatics platform pHinder, we identified a triad of buried acidic residues shared by all three receptors, a feature distinct from all other human GPCRs. Phylogenetic analysis shows the triad emerged in GPR65, the immediate ancestor of GPR4 and GPR68. To understand the evolutionary and mechanistic importance of these triad residues, we developed deep variant profiling, a yeast-based technology that utilizes high-throughput CRISPR to build and profile large libraries of GPCR variants. Using deep variant profiling and GPCR assays in HEK293 cells, we assessed the pH-sensing contributions of each triad residue in all three receptors. As predicted by our calculations, most triad mutations had profound effects consistent with direct regulation of receptor pH sensing. In addition, we found that an allosteric modulator of many class A GPCRs, Na+, synergistically regulated pH sensing by maintaining the pKa values of triad residues within the physiologically relevant pH range. As such, we show that all three receptors function as coincidence detectors of H+ and Na+. Taken together, these findings elucidate the molecular evolution and long-sought mechanism of GPR4, GPR65, and GPR68 pH sensing and provide pH-insensitive variants that should be valuable for assessing the therapeutic potential and (patho)physiological importance of GPCR pH sensing.

27 January 2021 in Structure
Verified
Journal Article
Closed access
GTGeoffrey J. Taghon
Geoffrey J. Taghon
JRJacob B. Rowe
Jacob B. Rowe
NKNicholas J. Kapolka
Nicholas J. Kapolka
DIDaniel G. Isom
Daniel G. Isom

19 April 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DWDazhi Wang
Dazhi Wang
IMIqbal Mahmud
Iqbal Mahmud
VTVijay S. Thakur
Vijay S. Thakur
STSze Kiat Tan
Sze Kiat Tan
DIDaniel G. Isom
Daniel G. Isom
SWScott M Welford
Scott M Welford
Clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, is largely incurable in the metastatic setting. ccRCC is characterized by excessive lipid accumulation that protects cells from stress and promotes tumor growth, suggesting that the underlying regulators of lipid storage could represent potential therapeutic targets. Here, we evaluated the regulatory roles of GPR1 and CMKLR1, two G protein–coupled receptors of the protumorigenic adipokine chemerin that is involved in ccRCC lipid metabolism. Both genetic and pharmacologic suppression of either receptor suppressed lipid formation and induced multiple forms of cell death, including apoptosis, ferroptosis, and autophagy, thereby significantly impeding ccRCC growth in cell lines and patient-derived xenograft models. Comprehensive lipidomic and transcriptomic profiling of receptor competent and depleted cells revealed overlapping and unique signaling of the receptors granting control over triglyceride synthesis, ceramide production, and fatty acid saturation and class production. Mechanistically, both receptors enforced suppression of adipose triglyceride lipase, but each receptor also demonstrated distinct functions, such as the unique ability of CMKLR1 to control lipid uptake through regulation of sterol regulatory element–binding protein 1c and the CD36 scavenger receptor. Treating patient-derived xenograft models with the CMKLR1-targeting small molecule 2-(α-naphthoyl) ethyltrimethylammonium iodide (α-NETA) led to a dramatic reduction in tumor growth, lipid storage, and clear-cell morphology. Together, these findings provide mechanistic insights into lipid regulation in ccRCC and identify a targetable axis at the core of the histologic definition of this tumor that could be exploited therapeutically. Significance: Extracellular control of lipid accumulation via G protein receptor–mediated cell signaling is a metabolic vulnerability in clear cell renal cell carcinoma, which depends on lipid storage to avoid oxidative toxicity.

6 July 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NKNicholas J. Kapolka
Nicholas J. Kapolka
JRJacob B. Rowe
Jacob B. Rowe
GTGeoffrey J. Taghon
Geoffrey J. Taghon
WMWilliam M. Morgan
William M. Morgan
COCorin R. O’sHea
Corin R. O’sHea
DIDaniel G. Isom
Daniel G. Isom
Significance: In complex biological systems, cells are constantly exposed to multiple physical and chemical stimuli. To decode such diverse inputs, cells use proteins embedded in the membrane to distinguish signal from noise and mount appropriate cellular responses. G protein-coupled receptors (GPCRs) represent the largest family of cell surface receptors in humans with more than 800 unique members. Here, we show that many GPCRs function as molecular coincidence detectors that couple proton (H + ) binding to receptor agonism. Our findings provide insights into the fundamentals of GPCR signaling and avenues for exploring GPCR responses to coincident H + signals generated by a variety of biological processes and pathological scenarios.